Longaeva Partners’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
Longaeva Partners's RCUS Position: Q3 2026 in Review
Longaeva Partners opened a new position in Arcus Biosciences (RCUS) in Q3 2026: 147,355 shares worth $3.81M. The stake represents 0.08% of the portfolio and ranks #203 among its holdings.
244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- Longaeva Partners held 147,355 shares of Arcus Biosciences worth $3.81M as of Q3 2026.
- Arcus Biosciences was a new Longaeva Partners position in Q3 2026.
- Arcus Biosciences made up 0.08% of Longaeva Partners's portfolio in Q3 2026, its #203 holding.
- 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.